National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

GM.CD40L cell vaccine
A cell-based vaccine composed of irradiated tumor cells transduced with granulocyte-macrophage colony-stimulating factor (GM-CSF) and CD40-ligand (CD40L) genes. Upon administration, this vaccine may stimulate an anti-tumoral dendritic cell-mediated host immune response. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:GM.CD40L



Previous:glycopeptide antibiotic, glycosylated recombinant human G-CSF AVI-014, glycosylated recombinant human interleukin-7, GM-CSF-encoding oncolytic herpes simplex virus, GM-K562 cell vaccine
Next:GM2-KLH vaccine, gold sodium thiomalate, goldenrod, goserelin, gossypol

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov